与神经类型的人群相比,PET测量中的粉样蛋白β在唐氏综合征中以加速的速度积累
Andrew McVea1,2, Alexandra DiFilippo1,2, Max McLachlan1,2
1Department of Medical Physics, University of Wisconsin - Madison School of Public Health, Madison, Wisconsin, USA.
概括
唐氏综合征 (DS) 患者与神经典型患者相比,粉样β (Aβ) 的积累速度要快40%. 这种在阿尔茨海默氏症中加速的粉样蛋白沉积对阿尔茨海默氏症 (AD) 研究和治疗策略有影响.
科学领域:
- 神经退行性疾病 神经退行性疾病
- 阿尔茨海默氏症疾病的发病因子
- 唐氏综合征研究 唐氏综合征研究
背景情况:
- 患有唐氏综合征 (DS) 的人患阿尔茨海默病 (AD) 的患病率显著更高.
- 粉样蛋白β (Aβ) 沉积是阿尔茨海默病的标志,与零星阿尔茨海默病相比,阿尔茨海默病患者的年龄较早.
- 在DS与零星AD中粉样蛋白积累的确切速率之前尚未确定.
研究的目的:
- 在唐氏综合征 (DS) 和神经类型 (NT) 个体中确定和比较粉样β (Aβ) 积累的速率.
- 为了调查DS和零星阿尔茨海默病 (AD) 群体之间粉样蛋白沉积轨迹的差异.
- 提供数据,可以为AD患者的AD临床试验的设计提供信息.
主要方法:
- 使用[C-11]PiB PET扫描在至少6年的时间内对粉样蛋白沉积的纵向分析.
- 包括20名患有DS的参与者和23名神经型 (NT) 参与者,他们过渡到粉样蛋白阳性 (Aβ+).
- 使用全球标准化吸收值比率 (SUVR) 量化粉样蛋白积累,并通过物流增长模型估计个体增长率 (r).
主要成果:
- 患有DS的参与者表现出0.28/年的平均粉样蛋白积累增长率,而在NT队列中为0.20/年.
- 这代表了DS患者的粉样蛋白积累率提高了40%.
- 在DS和NT队列之间的粉样蛋白阳性年龄没有观察到重叠.
结论:
- 纵向分析显示,唐氏综合征患者的粉样蛋白积累明显加快.
- 在DS中观察到的40%更快的粉样蛋白积累率对阿尔茨海默病研究具有关键意义.
- 这些发现强调了在设计治疗试验和监测DS患者疾病进展时需要考虑加速粉样蛋白动态的必要性.
相关概念视频
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...